Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a leading clinical-stage company ...

Integrated biomarker analyses confirm viral replication, interferon signaling, and a surge in tumor-infiltrating lymphocytes ...

A specially engineered antibody that can accurately deliver RNA treatments into hard-to-reach and hard-to-treat tumors ...

Oncolytics Biotech reveals promising survival data for pelareorep, an innovative immunotherapy, showing significant benefits ...

A specially engineered antibody capable of delivering RNA therapies to hard-to-reach, treatment-resistant tumors ...

Cancer immunotherapy has transformed the treatment landscape by helping the immune system recognize and attack tumors. At the ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

VANCOUVER – Baystreet.caNews Commentary – Budget cuts are on the horizon for funding scientific research, and if supported by ...

As lawmakers weigh potential cuts to scientific research funding, the outlook for developing cancer cures faces growing ...

A new test called PAC-MANN is designed to detect signs of pancreatic cancer in blood. It's still in development, but the hope is that it will help catch the deadly cancer early.

Precancerous cells must adapt to and overcome cellular stress and inflammation in order to progress and form malignant tumors. Now, researchers at University of California San Diego School of Medicine ...